Implantation of radioactive ¹²⁵I seeds improves the prognosis of locally advanced pancreatic cancer patients: A retrospective study

Abstract

Locally advanced pancreatic cancer is associated with a very poor prognosis. This study was performed to evaluate whether patients with locally advanced pancreatic cancer benefit from ¹²⁵I seed implantation. This retrospective study included 224 patients with locally advanced pancreatic cancer, with 137 patients (61.2%) in the implantation (IP) group and 87 (38.9%) in the non-implantation (NIP) group. The survival status, complications and objective curative effects were compared between the groups. The average operative time in the IP group was significantly longer than that in the NIP group (243±51 vs. 214±77 min). The tumor response rates were 9.5% and 0 at the 2nd month after surgery in the IP and NIP groups, respectively (P<0.05). The IP group exhibited a trend toward pain relief at the 6th month after surgery. The global health status scores of the IP group were higher than those of the NIP group at the 3rd and 6th month after surgery. The median survival time in the IP group was significantly longer than that in the NIP group. In conclusion, patients with locally advanced pancreatic cancer can benefit from ¹²⁵I seed implantation in terms of local tumor control, survival time, pain relief and quality of life.

Keywords

¹²⁵I seed implantation / locally advanced pancreatic cancer / pain relief / quality of life

References

[1] FortnerJG. Regional resection and pancreatic carcinoma. Surgery, 1973, 73(5): 799-800 PMID: 4697100

[2] BachellierP, NakanoH, OussoultzoglouPD, et al. . Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile. Am J Surg, 2001, 182(2): 120-129 PMID: 11574081

[3] CarrereN, SauvanetA, GoereD, et al. . Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg, 2006, 30(8): 1526-1535 PMID: 16855797

[4] ReddySK, TylerDS, PappasTN, et al. . Extended resection for pancreatic adenocarcinoma. Oncologist, 2007, 12(6): 654-663 PMID: 17602057

[5] GhanehP, CostelloE, NeoptolemosJP. Biology and management of pancreatic cancer. Gut, 2007, 56(8): 1134-1152 PMID: 17625148 PMCID: 1955499

[6] TemperoM, ArnolettiJP, Ben-JosefE, et al. . Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2007, 5(10): 998-1033 PMID: 18053426

[7] WangC, WuH, XiongJ, et al. . Pancreaticoduodenectomy with vascular resection for local advanced pancreatic head cancer: a single center retrospective study. J Gastrointest Surg, 2008, 12(12): 2183-2190 PMID: 18683009

[8] BurrisH 3, MooreMJ, AndersenJ, et al. . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 1997, 15(6): 2403-2413 PMID: 9196156

[9] GrunewaldR, AbbruzzeseJL, TarassoffP, et al. . Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine. Cancer Chemother Pharmacol, 1991, 27(4): 258-262 PMID: 1998982

[10] BahnBM, ErdekMA. Celiac plexus block and neurolysis for pancreatic cancer. Curr Pain Headache Rep, 2013, 17(2): 310 PMID: 23299904

[11] KaufmanM, SinghG, DasS, et al. . Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol, 2010, 44(2): 127-134 PMID: 19826273

[12] JinZ, DuY, LiZ, et al. . Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy, 2008, 40(4): 314-320 PMID: 18283622

[13] SunS, XuH, XinJ, et al. . Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy, 2006, 38(4): 399-403 PMID: 16680642

[14] WangKX, JinZD, DuYQ, et al. . EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain control in pancreatic carcinoma: a prospective pilot study. Gastrointest Endosc, 2012, 76(5): 945-952 PMID: 22841501

[15] XuKC, NiuLZ, HuYZ, et al. . A pilot study on combination of cryosurgery and (125)iodine seed implantation for treatment of locally advanced pancreatic cancer. World J Gastroenterol, 2008, 14(10): 1603-1611 PMID: 18330956 PMCID: 2693760

[16] WangCF, ZhaoP, LiYX, et al. . Role of 125I seed implantation in treatment of unresectable pancreatic cancer. Zhonghua Yi Xue Za Zhi (Chinese), 2010, 90(2): 92-95

[17] SchurichtAL, SpitzF, BarbotD, et al. . Intraoperative radiotherapy in the combined-modality management of pancreatic cancer. Am Surg, 1998, 64(11): 1043-1049 PMID: 9798766

[18] TemperoMA, ArnolettiJP, BehrmanSW, et al. . Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw, 2012, 10(6): 703-713 PMID: 22679115 PMCID: 3807091

[19] TherasseP, ArbuckSG, EisenhauerEA, et al. . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 2000, 92(3): 205-216 PMID: 10655437

[20] SprangersMA, CullA, BjordalK, et al. . The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for de veloping questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res, 1993, 2(4): 287-295

[21] OsobaD, RodriguesG, MylesJ, et al. . Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol, 1998, 16(1): 139-144 PMID: 9440735

[22] MoertelCG, FrytakS, HahnRG, et al. . Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer, 1981, 48(8): 1705-1710 PMID: 7284971

[23] LoehrerPJS, PowellME, CardenesHR, et al. . A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201. J Clin Oncol, 2008, 26(15): 431-436

[24] HuguetF, AndreT, HammelP, et al. . Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol, 2007, 25(3): 326-331 PMID: 17235048

[25] KimR, SaifMW I. s there an optimal neoadjuvant therapy for locally advanced pancreatic cancer. JOP, 2007, 8(3): 279-288 PMID: 17495356

[26] ChauffertB, MornexF, BonnetainF, et al. . Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol, 2008, 19(9): 1592-1599 PMID: 18467316

[27] RegineWF, WinterKA, AbramsRA, et al. . Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA, 2008, 299(9): 1019-1026 PMID: 18319412

[28] YovinoS, PoppeM, JabbourS, et al. . Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers. Int J Radiat Oncol Biol Phys, 2011, 79(1): 158-162 PMID: 20399035

[29] ChangDT, SchellenbergD, ShenJ, et al. . Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer, 2009, 115(3): 665-672 PMID: 19117351

[30] GuarneriA, BotticellaA, FilippiAR, et al. . 125I brachytherapy for localized prostate cancer: a single institution experience. Tumori, 2013, 99(1): 83-87 PMID: 23549005

[31] AkaneS, HiromichiI, TakefumiS, et al. . 125Iodine monotherapy for Japanese men with low- and intermediate-risk prostate cancer: outcomes after 5 years of follow-up. J Radiat Res, 2013, 55(2): 328-333

[32] BaltasD, LymperopoulouG, LofflerE, et al. . A radiobiological investigation on dose and dose rate for permanent implant brachytherapy of breast using 125I or 103Pd sources. Med Phys, 2010, 37(6): 2572-2586 PMID: 20632569

[33] GaoF, LiC, GuY, et al. . CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: effectiveness and safety in 16 patients. Eur J Radiol, 2013, 82(2): e70-75 PMID: 23040418

[34] ZhangS, ZhengY, YuP, et al. . The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer. J Cancer Res Clin Oncol, 2011, 137(12): 1813-1822 PMID: 21922327

[35] D'AngioG, HilarisBS, ArthurK, et al. . Iodine 125 implantation for unresectable cancer of the pancreas. Postgrad Med, 1970, 47(3): 226-230 PMID: 5418280

[36] ShipleyWU, NardiGL, CohenAM, et al. . Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma: a comparative study to surgical resection. Cancer, 1980, 45(4): 709-714 PMID: 6244074

[37] MohiuddinM, RosatoF, BarbotD, et al. . Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys, 1992, 23(2): 305-311 PMID: 1587751

[38] ZouYP, LiWM, ZhengF, et al. . Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer. World J Gastroenterol, 2010, 16(40): 5104-5110 PMID: 20976848 PMCID: 2965288

[39] ZhangFJ, WuPH, ZhaoM, et al. . CT guided radioactive seed 125I implantation in treatment of pancreatic cancer. Zhonghua Yi Xue Za Zhi (Chinese), 2006, 86(4): 223-227

[40] ZhongminW, YuL, FenjuL, et al. . Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Eur Radiol, 2010, 20(7): 1786-1791 PMID: 20069424

[41] YuYP, JiangHT, YaoZ, et al. . Feasibility and safety of CT-guided percutaneous needle biopsy and subsequent iodine-125 seed interstitial implantation for pancreatic cancer. Zhonghua Zhong Liu Za Zhi (Chinese), 2013, 35(8): 608-612

[42] JoyceF, BurcharthF, HolmHH, et al. . Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys, 1990, 19(4): 1049-1052 PMID: 1698755

[43] DuY, JinZ, MengH, et al. . Long-term effect of gemcitabine-combined endoscopic ultrasonography-guided brachytherapy in pancreatic cancer. J Interv Gastroenterol, 2013, 3(1): 18-24